Promising Outcomes from Phase I/II Gene Therapy Trial for GM2 Gangliosidosis, Including Tay-Sachs and Sandhoff Diseases
A groundbreaking clinical trial conducted at UMass Chan Medical School has demonstrated promising biochemical correction in patients afflicted with GM2 ...
